A detailed history of One Charles Private Wealth Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, One Charles Private Wealth Services, LLC holds 4,879 shares of ABBV stock, worth $831,137. This represents 0.38% of its overall portfolio holdings.

Number of Shares
4,879
Previous 4,850 0.6%
Holding current value
$831,137
Previous $831,000 15.88%
% of portfolio
0.38%
Previous 0.35%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $4,751 - $5,780
29 Added 0.6%
4,879 $963,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $5,572 - $6,507
-36 Reduced 0.74%
4,850 $831,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.04%
4,886 $889,000
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $49,536 - $55,789
-360 Reduced 6.86%
4,884 $756,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $12,557 - $14,537
-94 Reduced 1.76%
5,244 $781,000
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $338,298 - $420,989
2,553 Added 91.67%
5,338 $719,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $9,833 - $11,324
-68 Reduced 2.38%
2,785 $443,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $12,862 - $15,425
-93 Reduced 3.16%
2,853 $461,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $5,642 - $7,173
-41 Reduced 1.37%
2,946 $448,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $68,893 - $85,477
522 Added 21.18%
2,987 $484,000
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $42,649 - $53,964
-397 Reduced 13.87%
2,465 $334,000
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $7,235 - $8,213
68 Added 2.43%
2,862 $309,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $293,956 - $327,484
2,794 New
2,794 $315,000
Q3 2020

Oct 20, 2020

SELL
$85.91 - $100.83 $235,737 - $276,677
-2,744 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $201,327 - $269,405
2,744 New
2,744 $253,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track One Charles Private Wealth Services, LLC Portfolio

Follow One Charles Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Charles Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Charles Private Wealth Services, LLC with notifications on news.